Lesson 34 of 36 · 15 min
Dose-response & animal-to-human translation
Dose-response is a biological relationship, not a rule that doubling an amount doubles the benefit. Animal-to-human translation is even more complex because species, exposure, metabolism and endpoints can all change.
Dose-response shapes
More exposure can produce more effect, a plateau, no additional benefit or more toxicity.
Dose-response
More exposure does not guarantee proportionally more benefit.
A conceptual dose-response map showing increasing effect, diminishing returns and a rising adverse-effect burden.
Part of the curve may show more effect as exposure increases.
Additional exposure can add little benefit while tolerability worsens.
The shape and location of a real dose-response curve must come from compound-specific evidence in the relevant population and formulation.
Linear region
Within part of a curve, increasing exposure may produce a roughly proportional change.
Plateau
Receptor occupancy or downstream biology can reach a point where additional exposure adds little effect.
Non-monotonic / complex
Some biological systems can show different responses at different ranges or competing effects.
Toxicity-limited
An effect can continue increasing while tolerability or safety makes higher exposure undesirable.
Animal translation
mg/kg is not a universal bridge between species.
Body weight alone does not account for differences in metabolism, receptor biology, absorption, clearance or exposure. A rat amount divided or multiplied by weight does not become a validated human amount.
First-in-human development uses toxicology, pharmacokinetics, pharmacology, safety factors and other evidence to choose starting exposures. The process is deliberately more conservative than arithmetic scaling alone.
BPC-157 as a case study
A large animal literature still cannot define a human protocol.
BPC-157 has been studied using different animal species, injury models, routes and experimental amounts. Those studies can support biological hypotheses and justify clinical investigation.
Without robust human dose-finding and outcome studies, converting an animal regimen into a human schedule would create false precision rather than evidence.
Translation rule
Animal evidence can justify a human question. It cannot answer the human dose question by itself.
Translation requires new pharmacology and dose-finding evidence in the target species and population.
Key takeaways
- ✓Dose-response relationships are not necessarily linear.
- ✓A higher dose can add little benefit while increasing adverse effects.
- ✓Animal mg/kg values do not translate directly into validated human amounts.
- ✓Species differences in exposure, metabolism and receptor biology matter.
- ✓Human dose-finding is an evidence-generation step, not a unit-conversion exercise.
Further reading
Lesson finished
Ready for the checkpoint?
The quiz opens on its own page. Get every answer correct to mark this lesson complete and continue.
Take lesson quiz →Previous
PK, PD, half-life & exposure ←
Next lesson
Systematic reviews & meta-analysis →
Continue when you are ready, or come back to this lesson whenever you need a refresher.